photo of

Details

Role Group Leader
Group SAEFVIC

Contact

Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the Victorian Safety Service and the Melbourne Vaccine Education Centre (MVEC) where he leads a team of more than 30 staff members. Prof Crawford is Head of Immunisation Services at The Royal Children’s Hospital (RCH) and Chair of the Victorian Specialist Immunisation Services (VicSIS).

In 2021, Prof Crawford was appointed the Chair of the Australian Therapeutic Advisory Group on Immunisation (ATAGI), Ex-officio Member of COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group (SITAG), Member of Department of Foreign Affairs and Trade (DFAT) COVID-19 vaccine Expert Advisory Group (EAG), Member of the Victorian Department of Health, COVID-19 vaccine Expert Advisory Group (EAG), member of Vaccination Special Interest Group (VACSIG)/ Australasian Society for Infectious Diseases (ASID), and the Victorian representative of TGA-JIC (Jurisdictional Immunisation Co-ordinators) vaccine safety meetings with Australian Government Department of Health. Internationally, Prof Crawford is the founding/steering committee member of the International Specialist Immunisation Services (InSIS) network in Canada, a member of the World Health Organisation (WHO), Geneva and most recently appointed as the WPRO (Western Pacific Region) Representative of the GNN (Global NITAG Network) steering committee in WHO Geneva.
Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the...
Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the Victorian Safety Service and the Melbourne Vaccine Education Centre (MVEC) where he leads a team of more than 30 staff members. Prof Crawford is Head of Immunisation Services at The Royal Children’s Hospital (RCH) and Chair of the Victorian Specialist Immunisation Services (VicSIS).

In 2021, Prof Crawford was appointed the Chair of the Australian Therapeutic Advisory Group on Immunisation (ATAGI), Ex-officio Member of COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group (SITAG), Member of Department of Foreign Affairs and Trade (DFAT) COVID-19 vaccine Expert Advisory Group (EAG), Member of the Victorian Department of Health, COVID-19 vaccine Expert Advisory Group (EAG), member of Vaccination Special Interest Group (VACSIG)/ Australasian Society for Infectious Diseases (ASID), and the Victorian representative of TGA-JIC (Jurisdictional Immunisation Co-ordinators) vaccine safety meetings with Australian Government Department of Health. Internationally, Prof Crawford is the founding/steering committee member of the International Specialist Immunisation Services (InSIS) network in Canada, a member of the World Health Organisation (WHO), Geneva and most recently appointed as the WPRO (Western Pacific Region) Representative of the GNN (Global NITAG Network) steering committee in WHO Geneva.

Top Publications

  • Lopez, L, Burgner, D, Glover, C, Carr, J, Clark, J, Boast, A, Vasilunas, N, McMullan, B, Francis, JR, Bowen, AC, et al. Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant. The Lancet Regional Health - Western Pacific 27: 100604 2022
    view publication
  • Williams, P, Koirala, A, Saravanos, GL, Lopez, LK, Glover, C, Sharma, K, Williams, T, Carey, E, Shaw, N, Dickens, E, et al. COVID‐19 in New South Wales children during 2021: severity and clinical spectrum. The Medical Journal of Australia 217(6) : 303 -310 2022
    view publication
  • Top, KA, Chen, RT, Levy, O, Ozonoff, A, Carleton, B, Crawford, NW, Creech, CB, Kochhar, S, Poland, GA, Gutu, K, et al. Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clinical Infectious Diseases 75(Suppl 1) : s11 -s17 2022
    view publication
  • Koirala, A, Gidding, HF, Vette, K, Macartney, K, Wood, N, Britton, PN, Clark, JE, Wadia, U, Richmond, P, Bartlett, A, et al. The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021. The Medical Journal of Australia 217(1) : 43 -45 2022
    view publication
  • Rowntree, LC, Nguyen, THO, Kedzierski, L, Neeland, MR, Petersen, J, Crawford, JC, Allen, LF, Clemens, EB, Chua, B, McQuilten, HA, et al. SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection. Immunity 55(7) : 1299 -1315.e4 2022
    view publication

Page 15 of 44